These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 25656082)
21. Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Sutton SS; Hardin JW; Bramley TJ; D'Souza AO; Bennett CL Am J Manag Care; 2016 Apr; 22(4):242-8. PubMed ID: 27143289 [TBL] [Abstract][Full Text] [Related]
22. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315 [TBL] [Abstract][Full Text] [Related]
23. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy. O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN; HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609 [TBL] [Abstract][Full Text] [Related]
24. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa. Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050 [TBL] [Abstract][Full Text] [Related]
25. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam. Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590 [TBL] [Abstract][Full Text] [Related]
26. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. Laurent C; Diakhaté N; Gueye NF; Touré MA; Sow PS; Faye MA; Gueye M; Lanièce I; Touré Kane C; Liégeois F; Vergne L; Mboup S; Badiane S; Ndoye I; Delaporte E AIDS; 2002 Jul; 16(10):1363-70. PubMed ID: 12131213 [TBL] [Abstract][Full Text] [Related]
27. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China. Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort. Shet A; Kumarasamy N; Poongulali S; Shastri S; Kumar DS; Rewari BB; Arumugam K; Antony J; De Costa A; D'Souza G Curr HIV Res; 2016; 14(1):71-9. PubMed ID: 26303008 [TBL] [Abstract][Full Text] [Related]
29. Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort Study. Fekade D; Weldegebreal T; Teklu AM; Damen M; Abdella S; Baraki N; Belayhun B; Berhan E; Kebede A; Assefa Y Ethiop J Health Sci; 2017 Feb; 27(Suppl 1):63-71. PubMed ID: 28465654 [TBL] [Abstract][Full Text] [Related]
31. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa. Fatti G; Mothibi E; Shaikh N; Grimwood A AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459 [TBL] [Abstract][Full Text] [Related]
32. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation. Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192 [TBL] [Abstract][Full Text] [Related]
34. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil. Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032 [TBL] [Abstract][Full Text] [Related]
35. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region). Seyoum A; Ndlovu P; Temesgen Z AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125 [TBL] [Abstract][Full Text] [Related]
37. Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance. Ramadhani HO; Muiruri C; Maro VP; Nyombi B; Omondi M; Mushi JB; Lirhunde ES; Bartlett JA AIDS Behav; 2018 May; 22(5):1671-1678. PubMed ID: 28185021 [TBL] [Abstract][Full Text] [Related]
38. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention. Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393 [TBL] [Abstract][Full Text] [Related]
39. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384 [TBL] [Abstract][Full Text] [Related]
40. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]